Latest News for: abbvie

Edit

Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc (Form 6-K) (Genmab A/S)

Public Technologies 24 Mar 2025
Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. Company Announcement ● AbbVie Inc ... AbbVie Inc. (AbbVie) has filed a complaint in the U.S ... AbbVie is seeking damages and broad injunctive reliefs.
Edit

Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. (Genmab A/S)

Public Technologies 22 Mar 2025
2025-03-22 04.28.47 CET Genmab A/S - Inside information Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. Company Announcement AbbVie Inc ... AbbVie Inc. (AbbVie) has filed a complaint in the U.S.
Edit

Parkinson’s Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis | AbbVie, ...

GetNews 20 Mar 2025
In September 2024, AbbVie’s recently acquired Parkinson’s disease treatment, tavapadon, demonstrated a significant reduction in disease burden in a Phase III trial.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (AbbVie Inc)

Public Technologies 18 Mar 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... Washington, D.C ... AbbVie Inc ... The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc ... AbbVie Inc.
Edit

Calls of the Day: United Airlines, Delta, IBM, Abbvie, Uber

CNBC 12 Mar 2025
The Investment Committee debate the latest Calls of the Day ... .
Edit

Initial Statement of Beneficial Ownership (Form 3) (AbbVie Inc)

Public Technologies 10 Mar 2025
AbbVie Inc ... (1) Balance in AbbVie Savings Program as of March 1, 2025 ... (2) Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program ... AbbVie Inc.
Edit

Preliminary Proxy Statement (Form PRE 14A) (AbbVie Inc)

Public Technologies 10 Mar 2025
The full 2023 ESG Action Report can be found at https.//www.abbvie.com/content/dam/abbvie-com2/pdfs/abbvie-esg-action-report.pdf ... For more information, visit https.//news.abbvie.com/AbbVie-ratings-and-recognition-fact-sheet.
Edit

AbbVie to Present at the Leerink Partners Global Healthcare Conference

KJAS 05 Mar 2025
NORTH CHICAGO, Ill., March 4, 2025 /PRNewswire/ -- AbbVie (NYSE. ABBV) will participate at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025. Management will participate in a fireside chat at 7.40 a.m. Central time ....
×